Tue Haldor Hansen
Overview
Explore the profile of Tue Haldor Hansen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
547
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stankevic E, Kern T, Borisevich D, Poulsen C, Madsen A, Hansen T, et al.
Sci Rep
. 2024 Jun;
14(1):14738.
PMID: 38926497
The microbial communities of the oral cavity are important elements of oral and systemic health. With emerging evidence highlighting the heritability of oral bacterial microbiota, this study aimed to identify...
2.
Samodova D, Hoel A, Hansen T, Clausen L, Telleus G, Marti H, et al.
Metabolism
. 2023 Dec;
152:155760.
PMID: 38104923
Aims/hypothesis: Anorexia Nervosa (AN) is a severe psychiatric disorder of an unknown etiology with a crude mortality rate of about 5 % per decade, making it one of the deadliest...
3.
Bruun C, Hansen T, Vinberg M, Kessing L, Coello K
Nutr Neurosci
. 2023 Nov;
27(8):899-912.
PMID: 37976103
Available evidence points to a possible role of Short Chain Fatty Acids (SCFAs) in mood disorders. This is the first systematic review to map the associations between SCFA levels and...
4.
Allesoe R, Lundgaard A, Hernandez Medina R, Aguayo-Orozco A, Johansen J, Nissen J, et al.
Nat Biotechnol
. 2023 May;
41(7):1026.
PMID: 37130959
No abstract available.
5.
Thirion F, Speyer H, Hansen T, Nielsen T, Fan Y, Le Chatelier E, et al.
Biol Psychiatry Glob Open Sci
. 2023 May;
3(2):283-291.
PMID: 37124355
Background: Schizophrenia (SCZ) is a heterogeneous neuropsychiatric disorder for which current treatment has insufficient efficacy and severe adverse effects. The modifiable gut microbiome might be a potential target for intervention...
6.
Fan Y, Stoving R, Berreira Ibraim S, Hyotylainen T, Thirion F, Arora T, et al.
Nat Microbiol
. 2023 Apr;
8(5):787-802.
PMID: 37069399
Anorexia nervosa (AN) is an eating disorder with a high mortality. About 95% of cases are women and it has a population prevalence of about 1%, but evidence-based treatment is...
7.
Allesoe R, Lundgaard A, Hernandez Medina R, Aguayo-Orozco A, Johansen J, Nissen J, et al.
Nat Biotechnol
. 2023 Jan;
41(3):399-408.
PMID: 36593394
The application of multiple omics technologies in biomedical cohorts has the potential to reveal patient-level disease characteristics and individualized response to treatment. However, the scale and heterogeneous nature of multi-modal...
8.
Wesolowska-Andersen A, Brorsson C, Bizzotto R, Mari A, Tura A, Koivula R, et al.
Cell Rep Med
. 2022 Feb;
3(1):100477.
PMID: 35106505
The presentation and underlying pathophysiology of type 2 diabetes (T2D) is complex and heterogeneous. Recent studies attempted to stratify T2D into distinct subgroups using data-driven approaches, but their clinical utility...
9.
Coello K, Hansen T, Sorensen N, Ottesen N, Miskowiak K, Pedersen O, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2021 Mar;
110:110300.
PMID: 33713734
Background Affective disorders (AD) have been associated with a higher prevalence of the gut Flavonifractor genus and a lower abundance of the gut Christensenellaceae family. Objective and methods By pooling...
10.
Pinna N, Anjana R, Saxena S, Dutta A, Gnanaprakash V, Rameshkumar G, et al.
Genome Med
. 2021 Mar;
13(1):36.
PMID: 33658065
Background: Recent studies have indicated an association of gut microbiota and microbial metabolites with type 2 diabetes mellitus (T2D). However, large-scale investigation of the gut microbiota of "prediabetic" (PD) subjects...